UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 342

Sortiert nach

Algorithmic Identification of Patients With Aspirin‐Exacerbated Respiratory Disease Using an Electronic Health Record

Otolaryngology-head and neck surgery, 2023-08, Vol.169 (2), p.253-257

2023

Volltextzugriff (PDF)

Relationship Between Alcohol Intolerance and Aspirin‐Exacerbated Respiratory Disease (AERD): Systematic Review

Otolaryngology-head and neck surgery, 2023-07, Vol.169 (1), p.12-20

2023

Volltextzugriff (PDF)

The Role of Surgery in Management of Samter’s Triad

Otolaryngology-head and neck surgery, 2016-08, Vol.155 (2), p.220-237

2016

Volltextzugriff (PDF)

Azithromycin Mechanisms of Action in CRS Include Epithelial Barrier Restoration and Type 1 Inflammation Reduction

Otolaryngology-head and neck surgery, 2023-10, Vol.169 (4), p.1055-1063

2023

Volltextzugriff (PDF)

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease

Clinical and experimental allergy, 2013-08, Vol.43 (8), p.874-880

2013

Volltextzugriff (PDF)

Long‐term clinical outcomes of aspirin‐exacerbated respiratory disease: Real‐world data from an adult asthma cohort

Clinical and experimental allergy, 2023-09, Vol.53 (9), p.941-950

2023

Volltextzugriff (PDF)

Co‐treatment of non‐steroidal anti‐inflammatory drug‐exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization

Clinical and experimental allergy, 2023-09, Vol.53 (9), p.974-977

2023

Volltextzugriff (PDF)

Loss of smell in patients with aspirin‐exacerbated respiratory disease impacts mental health and quality of life

Clinical and experimental allergy, 2022-12, Vol.52 (12), p.1414-1421

2022

Volltextzugriff (PDF)

Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease

Clinical and experimental allergy, 2021-08, Vol.51 (8), p.1046-1056

2021

Volltextzugriff (PDF)

Targeted Molecular Therapies in Allergy and Rhinology

Otolaryngology-head and neck surgery, 2021-01, Vol.164 (1_suppl), p.S1-S21

2021

Volltextzugriff (PDF)

Pharmacogenomics of off‐target adverse drug reactions

British journal of clinical pharmacology, 2017-09, Vol.83 (9), p.1896-1911

2017

Volltextzugriff (PDF)

NSAID‐exacerbated respiratory disease: a meta‐analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity

Allergy (Copenhagen), 2015-07, Vol.70 (7), p.828-835

2015

Volltextzugriff (PDF)

Urine Leukotriene E4: Implications as a Biomarker in Chronic Rhinosinusitis

Otolaryngology-head and neck surgery, 2022-02, Vol.166 (2), p.224-232

2022

Volltextzugriff (PDF)

Case‐based dynamic learning of the NEPPC asthma and anosmia: Typical presentation in an atypical age

Pediatric pulmonology, 2022-04, Vol.57 (4), p.800-806

2022

Volltextzugriff (PDF)

Low‐dose aspirin desensitization in individuals with aspirin‐exacerbated respiratory disease

Allergy (Copenhagen), 2013-05, Vol.68 (5), p.659-665

2013

Volltextzugriff (PDF)

Influence of daily aspirin therapy on ACE2 expression and function—implications for SARS‐CoV‐2 and patients with aspirin‐exacerbated respiratory disease

Clinical and experimental allergy, 2021-07, Vol.51 (7), p.968-971

2021

Volltextzugriff (PDF)

Metamizole‐induced reactions as a paradigm of drug hypersensitivity: Non‐allergic reactions, anaphylaxis, and delayed‐type allergy

Clinical and experimental allergy, 2020-09, Vol.50 (9), p.1103-1106

2020

Volltextzugriff (PDF)

Central compartment atopic disease: outcomes compared with other subtypes of chronic rhinosinusitis with nasal polyps

International forum of allergy & rhinology, 2021-11, Vol.11 (11), p.1549-1556

2021

Volltextzugriff (PDF)

Cost‐effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin‐exacerbated respiratory disease

International forum of allergy & rhinology, 2021-12, Vol.11 (12), p.1626-1636

2021

Volltextzugriff (PDF)

Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin‐exacerbated respiratory disease

International forum of allergy & rhinology, 2018-01, Vol.8 (1), p.49-53

2018

Volltextzugriff (PDF)

Metabolomic analysis identifies potential diagnostic biomarkers for aspirin‐exacerbated respiratory disease

Clinical and experimental allergy, 2017-01, Vol.47 (1), p.37-47

2017

Volltextzugriff (PDF)

Elevated Urine Leukotriene E4 Is Associated With Worse Objective Markers in Nasal Polyposis Patients

The Laryngoscope, 2021-05, Vol.131 (5), p.961-966

2021

Volltextzugriff (PDF)

Factors affecting revision rate of chronic rhinosinusitis

Laryngoscope investigative otolaryngology, 2016-08, Vol.1 (4), p.96-105

2016

Volltextzugriff (PDF)

Surfactant protein D alleviates eosinophil‐mediated airway inflammation and remodeling in patients with aspirin‐exacerbated respiratory disease

Allergy (Copenhagen), 2019-01, Vol.74 (1), p.78-88

2019

Volltextzugriff (PDF)

Clinical and pathologic perspectives on aspirin sensitivity and asthma

Journal of allergy and clinical immunology, 2006-10, Vol.118 (4), p.773-786

2006

Volltextzugriff (PDF)

1 – 25 von 342

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(319)
Mit Volltextzugriff
(279)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(277)
Science & Technology
(277)
Aspirin-Exacerbated Respiratory Disease
(275)
Humans
(216)
Asthma
(177)
Allergy
(176)
Aspirin
(152)
Immunology
(151)
Aspirin - Adverse Effects
(117)
Female
(101)
Respiratory Diseases
(99)
Male
(95)
Adult
(93)
Middle Aged
(91)
Nasal Polyps
(75)
Anti-Inflammatory Agents, Non-Steroidal - Adverse Effects
(70)
Chronic Rhinosinusitis
(65)
Aspirin Exacerbated Respiratory Disease
(63)
Otorhinolaryngology
(60)
Sinusitis
(54)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Algorithmic Identification of Patients With Aspirin‐Exacerbated Respiratory Disease Using an Electronic Health Record

Relationship Between Alcohol Intolerance and Aspirin‐Exacerbated Respiratory Disease (AERD): Systematic Review

The Role of Surgery in Management of Samter’s Triad

Azithromycin Mechanisms of Action in CRS Include Epithelial Barrier Restoration and Type 1 Inflammation Reduction

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease

Long‐term clinical outcomes of aspirin‐exacerbated respiratory disease: Real‐world data from an adult asthma cohort

Co‐treatment of non‐steroidal anti‐inflammatory drug‐exacerbated respiratory disease with dupilumab and aspirin therapy after desensitization

Loss of smell in patients with aspirin‐exacerbated respiratory disease impacts mental health and quality of life

Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease

Targeted Molecular Therapies in Allergy and Rhinology

Pharmacogenomics of off‐target adverse drug reactions

NSAID‐exacerbated respiratory disease: a meta‐analysis evaluating prevalence, mean provocative dose of aspirin and increased asthma morbidity

Urine Leukotriene E4: Implications as a Biomarker in Chronic Rhinosinusitis

Case‐based dynamic learning of the NEPPC asthma and anosmia: Typical presentation in an atypical age

Low‐dose aspirin desensitization in individuals with aspirin‐exacerbated respiratory disease

Influence of daily aspirin therapy on ACE2 expression and function—implications for SARS‐CoV‐2 and patients with aspirin‐exacerbated respiratory disease

Metamizole‐induced reactions as a paradigm of drug hypersensitivity: Non‐allergic reactions, anaphylaxis, and delayed‐type allergy

Central compartment atopic disease: outcomes compared with other subtypes of chronic rhinosinusitis with nasal polyps

Cost‐effectiveness analysis comparing dupilumab and aspirin desensitization therapy for chronic rhinosinusitis with nasal polyposis in aspirin‐exacerbated respiratory disease

Outcomes after complete endoscopic sinus surgery and aspirin desensitization in aspirin‐exacerbated respiratory disease

Metabolomic analysis identifies potential diagnostic biomarkers for aspirin‐exacerbated respiratory disease

Elevated Urine Leukotriene E4 Is Associated With Worse Objective Markers in Nasal Polyposis Patients

Factors affecting revision rate of chronic rhinosinusitis

Surfactant protein D alleviates eosinophil‐mediated airway inflammation and remodeling in patients with aspirin‐exacerbated respiratory disease

Clinical and pathologic perspectives on aspirin sensitivity and asthma

Suchergebnisse filtern